that govern drugmakers flooded social media platforms, promising rapid diagnoses, prescriptions and improved moods., setting off a second crisis. Between 2019 and 2022, the total number of Adderall and generic-equivalent prescriptions to treat ADHD increased 27 percent from 35.5 million to 45 million, according to the IQVIA National Prescription Audit.
“This is my life right now — calling pharmacies trying to find them,” said Mai Uchida, director of the Child Depression Program at Massachusetts General Hospital. She spends hours every day searching for the stimulants she prescribes a third of her patients.Uchida describes a process that is both a treasure hunt and a race against time: ringing pharmacy after pharmacy to find the right type and dosage of medicine, only to discover it has run out by the time her patient arrives to pick it up.
Uchida’s patients are lucky to have her as an advocate. It is now commonplace for many Americans with ADHD to spend hours a month calling a dozen or more pharmacies to find one that can fill a short, 30-day supply of Adderall. In rural areas, this can mean calling pharmacies 50 or more miles from home.
“These are people who are surviving on routine,” Uchida said. “Suddenly another wrench is thrown in, and it is really a burden for people who are already struggling with their neuro-developmental diseases.”At the height of the pandemic, global supply chain problems added to the drug shortage. Even now, manufacturers can’t keep up with patient demand. At least
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SciTechDaily1 - 🏆 84. / 68 Read more »